Speaker
Gregory Yh Lip
University of Liverpool,
Liverpool
(United Kingdom of Great Britain & Northern Ireland )
Speciality :
Atrial Fibrillation
115 presentations
115
presentations
from this speaker
2020 ESC Guidelines on Atrial Fibrillation - Live.
Event :
ESC Congress 2020
Session :
2020 ESC Guidelines on Atrial Fibrillation - Live
Speaker : G
Hindricks
(Leipzig,DE), IC
Van Gelder
(Groningen,NL), G
Boriani
(Castenaso-Bo,IT), GYH
Lip
(Liverpool,GB), C
Blomstrom-Lundqvist
(Uppsala,SE), E
Arbelo
(Barcelona,ES), TS
Potpara
(Belgrade,RS)
Summary and conclusions.
Event :
EHRA Essentials 4 You 2020
Session :
Recent developments in risk stratification and early AF detection for the improved prevention of stroke and systemic embolic events
Speaker : GYH
Lip
(Liverpool,GB)
Industry Essentials organised by Daiichi Sankyo Europe
Welcome, introduction and summary of hot topics discussed.
Event :
EHRA Essentials 4 You 2020
Session :
Recent developments in risk stratification and early AF detection for the improved prevention of stroke and systemic embolic events
Speaker : GYH
Lip
(Liverpool,GB)
Industry Essentials organised by Daiichi Sankyo Europe
Who is at risk to develop atrial fibrillation?
Event :
EHRA Essentials 4 You 2020
Session :
EHRA/HRS/APHRS/LAHRS Expert Consensus 2020: risk assessment in cardiac arrhythmias: use the right tool for the right outcome in the right population
Speaker : GYH
Lip
(Liverpool,GB)
Establishing NOACs as standard of care in clinical practice
Event :
ESC Congress 2019
Session :
Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation
Speaker : GYH
Lip
(Liverpool,GB)
Sponsored by The Bristol-Myers Squibb/Pfizer Alliance
Beyond trials: learning from clinical practice.
Event :
ESC Congress 2018
Session :
Advances in anticoagulation to improve patient care in atrial fibrillation
Speaker : GYH
Lip
(Liverpool,GB)
Sponsored by Bristol-Myers Squibb and Pfizer Alliance
Introduction: balancing thrombosis and bleeding in AF/ACS/PCI.
Event :
ESC Congress 2018
Session :
2018 Joint European Consensus Document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions
Speaker : GYH
Lip
(Liverpool,GB)
Moving beyond pharmacologic therapy in cardiac arrhythmia management
Event :
ESC Congress 2018
Session :
Navigating the continuum of care in cardiac arrhythmia management
Speaker : R
De Caterina
(Pisa,IT), GYH
Lip
(Liverpool,GB), G
Hindricks
(Leipzig,DE), M
Duytschaever
(Brugge,BE)
Organised by Medscape Education, supported with an educational grant by Biosense Webster
Audience Q&A.
Event :
EHRA 2017
Session :
RE-CIRCUIT: uninterrupted dabigatran as a new strategy in atrial fibrillation ablation
Speaker : GYH
Lip
(Liverpool,GB)
Sponsored by Boehringer Ingelheim
What the consensus document says.
Event :
EHRA 2017
Session :
Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis
Speaker : GYH
Lip
(Liverpool,GB)
Stroke prevention
Event :
ESC Congress 2016
Session :
Atrial fibrillation
Speaker : GYH
Lip
(Liverpool,GB)
AEGEAN: Discussant review.
Event :
ESC Congress 2015
Session :
Hot Line II - Atrial fibrillation/Pacing
Speaker : GYH
Lip
(Liverpool,GB)
Anticoagulation with old and new drugs.
Event :
EHRA 2015
Session :
Differences in electrophysiology between Europe and Japan: do they really matter? An update of clinically relevant information
Speaker : GYH
Lip
(Liverpool,GB)
Anti-inflammatory agents.
Event :
EHRA 2015
Session :
Upstream treatment of atrial fibrillation: myth or reality?
Speaker : GYH
Lip
(Liverpool,GB)
Exploring real-world evidence for oral anticoagulation.
Event :
ESC Congress 2015
Session :
Exploring the universe of oral anticoagulation in patients with non-valvular atrial fibrillation: continuing the journey
Speaker : GYH
Lip
(Liverpool,GB)
Sponsored by BMS-Pfizer Alliance
Panel Discussion and closing remarks - Edoxaban – Engaging with the real world in atrial fibrillation.
Event :
ESC Congress 2015
Session :
Edoxaban – Engaging with the real world in atrial fibrillation
Speaker : C
Bode
(Freiburg,DE), R
De Caterina
(Pisa,IT), R
Kreutz
(Berlin,DE), C
Ruff
(Boston,US), J
Steffel
(Zurich,CH), GYH
Lip
(Liverpool,GB)
Sponsored by Daiichi Sankyo Europe GmbH
State-of-the-art: PCI in patients on NOACs.
Event :
ESC Congress 2015
Session :
State-of-the-art: Percutaneous Coronary Intervention (PCI) in patients on NOACs
Speaker : GYH
Lip
(Liverpool,GB), G
Nickenig
(Bonn,DE)
Sponsored by Boehringer Ingelheim
Atrial fibrillation.
Event :
ESC Congress 2013
Session :
Hypertension and the heart
Speaker : GYH
Lip
(Liverpool,GB)
Combination therapy.
Event :
ESC Congress 2013
Session :
Antithrombotics in heart failure
Speaker : GYH
Lip
(Liverpool,GB)